Michael Jerman - 27 Aug 2024 Form 4 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Director
Signature
/s/ Michael Jerman
Issuer symbol
TELO
Transactions as of
27 Aug 2024
Transactions value $
$0
Form type
4
Filing time
29 Aug 2024, 16:05:20 UTC
Previous filing
16 May 2024
Next filing
17 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELO Incentive Stock Options (right to buy) Award $0 +25K $0.00 25K 27 Aug 2024 Common Stock 25K $5.02 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.
F2 The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.